DIA Annual Meeting 2017: CRISPR, Disruptive Innovation Panels to be Moderated by Catalyst

Catalyst will moderate two panel discussions exploring various types of disruptive innovation during the DIA’s 2017 Annual Meeting.

On June 20, Catalyst President Nancy Bradish Myers will moderate a panel exploring “Regulatory Frameworks: How Can Regulators Facilitate Disruptive Innovation?” This will be a wide-ranging discussion, across different technologies and innovations, for example gene therapy/regenerative medicine and other cutting edge advanced technologies.

On June 21, she will moderate a panel looking at “CRISPR: Regulatory Challenges in the Gene Editing Revolution.” She will be joined by panelists representing FDA and innovators in the gene editing space.

DIA 2017 will be held June 19-22, 2017 in Chicago.